Tempus AI

Tempus AI DSCR

The Debt Service Coverage Ratio (DSCR) of Tempus AI (TEM) as of Oct 15, 2026 is -0.18. In the previous year, Debt Service Coverage Ratio (DSCR) was -0.43 — a change of -59.47% (higher).

DSCR

-0.18

YoY

-59.47%

Last updated:

Debt Service Coverage Ratio (DSCR) of Tempus AI is 2025 -0.18 . Debt Service Coverage Ratio (DSCR) of Tempus AI was 2024 -0.43 . It decreases by -59.47% higher compared to the previous year.

The Tempus AI DSCR history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

DSCR
Date
DSCR
Jan 1, 2019
-45.18 USD
Jan 1, 2020
-0.82 USD
Jan 1, 2021
-0.89 USD
Jan 1, 2022
-0.43 USD
Jan 1, 2023
-0.48 USD
Jan 1, 2024
-0.43 USD
Jan 1, 2025
-0.18 USD
The Tempus AI DSCR history
YEARDSCRYoY
-0.18-59.47%
-0.43-8.92%
-0.48+10.47%
-0.43-51.36%
-0.89+7.99%
-0.82-98.18%
-45.18—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tempus AI Stock analysis

What does Tempus AI do? Tempus AI Inc, listed on the stock market with ticker TEM and ISIN US88023B1035, is a U.S.-based company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Headquartered in Chicago, the company employs approximately 3,800 people. Tempus AI Inc completed its initial public offering (IPO) on June 14, 2024. The company's website is www.tempus.com. Tempus AI Inc provides next-generation diagnostics across multiple disease areas, utilizing data and analytics to support personalized medicine. Its product offerings include genomics, data analytics, and artificial intelligence applications. The genomics division operates laboratories that deliver next-generation sequencing, diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and various anatomic and molecular pathology testing services. The AI applications division focuses on developing algorithmic diagnostics, software as a medical device, and clinical decision support tools. The company's primary AI platform, Next, uses machine learning to analyze routinely generated data, aiming to proactively identify and address care gaps for patients in oncology and cardiology. Tempus AI Inc is positioned as a technology company within the life sciences sector, leveraging advanced data capabilities to enhance medical care and treatment personalization. Tempus AI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tempus AI stock

Debt Service Coverage Ratio (DSCR) of Tempus AI is -0.18 in 2025.

Debt Service Coverage Ratio (DSCR) of Tempus AI changed from -0.43 to -0.18, representing a -59.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Service Coverage Ratio (DSCR) Tempus AI since 2006 – with annual values, charts, and detailed analysis.

The DSCR measures a company's ability to service its debt obligations from operating income. A ratio above 1.0 indicates sufficient income to cover debt payments.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt Service Coverage Ratio (DSCR)'s Tempus AI with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Tempus AI

All Key Metrics — Tempus AI